We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Appeals Court Rejects Merck's Request For Fosamax Rehearing
Appeals Court Rejects Merck's Request For Fosamax Rehearing
May 3, 2005
A federal appeals court has rejected Merck’s request to reconsider a January ruling that struck down the company’s patent on blockbuster osteoporosis treatment Fosamax — a decision that opened the drug to generic competition a decade early.